APRI

Apricus Biosciences, Inc News Headlines

$1.22
*  
0.02
1.61%
Get APRI Alerts
*Delayed - data as of Jan. 23, 2015  -  Find a broker to begin trading APRI now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Endo International To Present At J.P. Morgan Conference; Webcast At 5:00 PM ET
1/12/2015 3:00:00 PM - RTT News


Apricus Biosciences To Present At Biotech Showcase; Webcast At 6:30 PM ET
1/12/2015 3:00:00 PM - RTT News


Pacira Q4 & 2014 Revenues to Come In Line with Estimates - Analyst Blog
1/9/2015 4:20:00 PM - Zacks.com


Valeant Up on Better-than-Expected 2015 Outlook, Eyes Deals - Analyst Blog
1/9/2015 5:50:00 AM - Investopedia


Pacira Q4 & 2014 Revenues to Come In Line with Estimates - Analyst Blog
1/9/2015 4:20:00 AM - Investopedia


BioLineRx Finishes Dose-Escalation in Phase I BL-8040 Study - Analyst Blog
1/8/2015 1:40:00 PM - Investopedia


BioLineRx Finishes Dose-Escalation in Phase I BL-8040 Study - Analyst Blog
1/8/2015 1:40:00 PM - Zacks.com


Zacks Rank #1 Additions for Wednesday - Tale of the Tape
1/7/2015 9:30:00 AM - Zacks.com


Will Apricus Biosciences (APRI) Continue to Surge Higher? - Tale of the Tape
1/7/2015 8:45:25 AM - Zacks.com


MediWound Ltd. (MDWD) in Focus: Stock Jumps 5.6% - Tale of the Tape
1/2/2015 9:18:00 AM - Zacks.com


OncoGenex to End Deal with Teva & Regain Custirsen Rights - Analyst Blog
12/31/2014 2:55:00 PM - Investopedia


OncoGenex to End Deal with Teva & Regain Custirsen Rights - Analyst Blog
12/31/2014 2:55:00 PM - Zacks.com


Apricus Biosciences And Vitaros: Update On The Launch
12/24/2014 1:21:00 PM - Seeking Alpha


Apricus Announces Plans To Further Commercialize Its ED Drug Vitaros In 2015
12/22/2014 6:03:00 PM - RTT News


Top-Rated Stock Picks and Most-Read Stories of the Week of December 1 for Nasdaq.com
12/9/2014 1:30:21 PM - Nasdaq.com Community


Health Care Sector Update for 12/04/2014: CYTX, KERX, APRI
12/4/2014 8:56:54 AM - MT Newswires


Apricus Biosciences Names Brian Dorsey Chief Development Officer
12/2/2014 7:38:00 AM - RTT News


Monday 10/27 Insider Buying Report: APRI, MTG
10/27/2014 11:37:55 AM - BNK Invest


Sector Update: Health Care
10/13/2014 7:58:56 AM - MT Newswires


Sector Update: Health-Care Stocks Mixed Pre-Bell
10/13/2014 7:58:43 AM - MT Newswires


Vivus Up On Erectile Dysfunction Drug - What Should Investors Expect?
9/19/2014 10:50:00 AM - Seeking Alpha


Apricus Biosciences: A Screaming Buy Or A Falling Knife?
8/25/2014 9:10:00 AM - Seeking Alpha


Apricus Biosciences' ED Treatment Vitaros Now in Germany - Analyst Blog
8/19/2014 4:10:00 PM - Zacks.com


Sector Update: Health Care Stocks Finish on Plus Side; Apricus Gains Following Commercial Launch in Germany
8/18/2014 3:01:03 PM - MT Newswires


Sector Update: Health Care
8/18/2014 3:00:29 PM - MT Newswires